Indian drugmakers are responding with geographic diversification, supply-chain resilience and acquisition of US assets to ...

A Japanese health ministry panel on Wednesday approved a plan to cut the price of Lecanemab, an Alzheimer's drug codeveloped by Japanese drugmaker Eisai Co. and US industry peer Biogen Inc., by 15 ...

Astera Labs (ALAB) recently reported strong Q2 2025 financial results, demonstrating a robust year-over-year growth in sales and net income, potentially influencing its impressive 143% stock price ...